Bigtec Private Limited: Pioneer in Point-of-Care Molecular Diagnostics
Bigtec Private Limited, often operating as Bigtec Labs, is an India-based MedTech company primarily engaged in the research, development, and manufacturing of innovative point-of-care diagnostic solutions. Headquartered in Bengaluru, Karnataka, the company's core mission is to democratize access to "gold standard" diagnostic tests for infectious diseases, specifically focusing on deployment in resource-limited and near-care settings across the globe. By developing technology that shifts complex molecular testing from centralized laboratories to the patient's first point of interaction with the healthcare system, Bigtec aims to enable precise, rather than presumptive, diagnosis, thereby facilitating earlier and more appropriate patient treatment.
The company's foundation rests on a multi-disciplinary approach, leveraging a diverse team of scientists and engineers with expertise spanning multiple fields. The in-house research and development capabilities, which became a wholly-owned subsidiary of Molbio Diagnostics Private Limited in 2015, integrate specialized knowledge in:
Continue…
- Biology: Molecular and cell biology, including advanced assay development.
- Chemistry: Organic, Inorganic, and Electrochemistry.
- Engineering: Hardware and Mechanical design, Micro-Electro-Mechanical Systems (MEMS), Optics, and Analogue and Embedded Electronics.
- Software: Development of dashboards, device connectivity solutions, and applications of Artificial Intelligence (AI) and Machine Learning (ML).
Products and Services
Bigtec Private Limited's product portfolio is centered on its pioneering work in Nucleic Acid Amplification Test (NAAT) technology, adapted for decentralized use. The flagship offering and its associated components are as follows:
TrueLab Portable PCR Platform (Truenat)
The TrueLab platform is Bigtec???s most significant innovation, recognized for developing the world's first near-care Polymerase Chain Reaction (PCR) platform for clinical diagnosis. This system utilizes lab-on-a-chip technology, which employs microfluidic devices to perform the entire diagnostic process???including sample preparation, complex bio-chemical reactions, screening, and detection???on a single, miniaturized chip.
- Functionality: The platform provides molecular diagnostic results in as little as 60 minutes, a significant improvement over traditional laboratory-based PCR testing, which can take over 24 hours. This rapid turnaround time is crucial for immediate patient management in the fight against high-burden infectious diseases.
- Impact: The Truenat devices are deployed worldwide, playing a crucial role in diagnostic programs for major global health threats. For example, the platform has been instrumental in India's efforts against Tuberculosis (TB) and COVID-19, conducting over 12 million COVID tests in the country and contributing to a six-fold increase in rapid molecular TB testing in regions like the Democratic Republic of Congo. The platform is designed to be user-friendly, requiring minimal training and only basic infrastructure for deployment in primary healthcare centers.
Truepep - Auto Universal Cartridge Based Sample Prep Device
The Truepep device is an integrated component of the TrueLab platform, specifically designed for automated and universal sample preparation. This device is critical for the seamless, near-care functionality of the PCR system, preparing the biological sample for the subsequent amplification and detection steps contained within the diagnostic cartridge.
PRORAD Atlas Ultra Portable X-Ray Machine
In expanding its near-care diagnostics portfolio, Bigtec has also entered the medical imaging space with the PRORAD Atlas. This is an ultra-portable X-Ray machine designed for "out of clinic" chest imaging. It integrates AI-based reporting at the point-of-care, making it a valuable tool for rapid and decentralized screening, such as for Tuberculosis.
Advanced Diagnostic Research and Development Services
Beyond its major product lines, Bigtec is continuously engaged in developing next-generation diagnostic solutions and platforms.
- Biosensing Domain: The company's core competency lies in solving problems and creating devices and tests in the biosensing domain through the seamless integration of engineering and scientific disciplines.
- Breath-Based Diagnostics: Bigtec is involved in research for Volatile Organic Compound (VOC) detection for healthcare diagnostics, which includes a collaboration with academic institutions for developing sensor systems for breath-based diagnostics.
- Technology Development: The company???s services also encompass specialized areas like Electronics Integrating Manufacturing, Electronics Chip Innovation, and the provision of Chemistry Lab Equipment.
The overall business of Bigtec Private Limited is defined by its strategic focus on developing clinical diagnostics and biosensors that are accessible, affordable, and accurate for use in any setting, fundamentally changing the landscape of molecular testing for infectious diseases.
